A commissioned 'repeat prescription review' service in community pharmacy should be explored to improve medicines adherence and patient understanding, the Royal Pharmaceutical Society (RPS) and Royal College of GPs (RCGP) have suggested.
The recommendation comes as part of a new repeat prescribing toolkit, in what is believed to be the first guidance of its kind for 20 years.
The 92-page blueprint encourages community pharmacies, GP practices, and primary care networks (PCNs) to work together to understand their repeat prescribing processes through a self-assessment exercise.
It sets out how teams could map out their prescribing processes and make changes to improve efficiency for healthcare teams as well as patient safety.
But the RPS and RCGP noted that 'some areas were outside the scope' of their working group, including 'changes in commissioning responsibilities or regulatory arrangements'.
They therefore issued 10 recommendations to support the work.
Related Article: OBE award the ‘pinnacle of my career’ says community pharmacist
Funding recommended for community pharmacies to improve repeat prescribing
In particular, they encouraged commissioners to
And they suggested that 't
The need to
The guidance also called for commissioners to explore '
And it advised practices 'to make use of the nationally commissioned new medicines service (NMS) from their local community pharmacies'.
Hospital discharge process must be improved
The RPS and RCGP also highlighted the need to 'expedite digital solutions' that would allow hospital discharge medicines information to link into the patient record.
And they noted that utilisation of the Discharge Medicines Service (DMS) in England was 'currently not fully optimised'.
Related Article: ‘Streamlined’ DMS claims process to launch in July
'The DMS enables hospitals to digitally share information about medication changes with the patient’s usual community pharmacy and has been shown to reduce readmission rates at 30, 60 and 90 days. Trusts and community pharmacies should make the most of this opportunity to reduce avoidable harm,' the guidance recommended.
The RPS and RCGP asked secondary care and specialist services 'to make very clear to primary care on discharge of a patient from hospital, the reasons for medicines to be prescribed on repeat, the indication and the intended duration of therapy'.
They added: 'Any medicines stopped need to also be clearly documented with a reason for the cessation of therapy.'
The toolkit noted an example of a 2019 medication safety incident in which a patient was discharged from hospital with a prescription for 100 mL of oral morphine sulphate 10 mg/5 mL solution for acute pain relief.
But after discharge, the patient began to receive 300 mL of oral morphine sulphate 10 mg/5 mL regularly on repeat prescription, which continued, unchecked for four months.
Shortly after this, the patient died, and toxicology tests revealed a fatal level of morphine in their blood.
The coroner raised concerns that the local community pharmacy had requested repeat prescriptions without seeking the view of the patient. And they asked all pharmacists making a request for a prescription to a GP to ensure that the wishes of the patient are obtained, save in circumstances where this is not possible such as where the patient lacks capacity.
Related Article: RPS new director for England will build a ‘vibrant future’ for pharmacy
The new guidance asked general practice and community pharmacies to ensure that all high-risk medicines and particularly opioids, antidepressants and hypnotic medicines, 'are treated very carefully where they are to be prescribed as a repeat medication'.
James Davies, RPS director for England, told The Pharmacist that while 'many pharmacies have ceased their repeat ordering services or moved to a digital solution where the patient places the order', the RPS 'wanted to highlight the issue in the toolkit to remind pharmacy professionals that repeat ordering services need to have clear arrangements for consent'.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.